ALFA FinderBSE filing, BSE: 544943. Summary written from the filing by ALFA Finder's alert engine.
Himalaya Nutravedics India Ltd: key numbers
- Share price
- ₹169.85
- Market cap
- ₹149.6 Cr
- Revenue (annual)
- ₹43.07 Cr
- Net profit (annual)
- ₹7.39 Cr
- P/E (TTM)
- 20.2×Sector 43.7×
- Promoter holding
- 68.13%
- FII holding
- 6.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Himalaya Nutravedics India Ltd
All →Himalaya Nutravedics India Investor Presentation: Key Takeaways
H1 FY27 revenue ₹2,739.8L (+35.8% YoY), EBITDA ₹567.2L (+51.1%), margin 20.7% (+210bps), PAT ₹444.1L (+34.6%). Own-brand share rose to 54.7%; BSE SME listing done.
Himalaya Nutravedics India H1 FY27 Results: Net Profit ₹4.4 Cr, Up 33.3% YoY
Himalaya Nutravedics approved un-audited H1 FY27 results: revenue of Rs 2741.43 Lakh and profit after tax of Rs 444.11 Lakh. The board also appointed Srinivasachary & Co. as internal auditor.
- Key figure
- Net profit ₹4.4 Cr · +33.3% YoY
Himalaya Nutravedics India Board Meeting Date
HIMALAYA NUTRAVEDICS INDIA has given prior intimation of a board meeting on 12 November 2026 to consider unaudited standalone half-yearly results for the period ended September 2026. The trading window is closed from 1 October 2026 to 14 November 2026.
Himalaya Nutravedics India Other Announcement
Himalaya Nutravedics India Ltd intimated BSE of its updated CIN and MCA master data after listing on the BSE SME Platform. The filing is a routine administrative record update with no financial or operational impact.
Himalaya Nutravedics India Price Movement Clarification
Himalaya Nutravedics India Limited clarified that recent share price movements are market-driven and not linked to any undisclosed price-sensitive information or material events.
Himalaya Nutravedics India Other Announcement
Himalaya Nutravedics India Limited has filed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr